Core One Labs (CLABF) Stock Price, News & Analysis

Company Overview

Core One Labs Inc. (OTCMKTS: CLABF) is a clinical-stage biotechnology company specializing in the development and commercialization of proprietary cannabinoid drug-delivery platforms. The company’s core focus lies in creating advanced formulations to improve the bioavailability, stability and controlled release of cannabinoids, including cannabidiol (CBD) and other minor cannabinoids, for therapeutic applications. By leveraging enzyme-catalyzed, isotopically labeled synthesis technology, Core One Labs aims to address key challenges in consistency and dosing that have historically limited the broader pharmaceutical adoption of cannabinoid-based therapies.

At the heart of Core One Labs’ business model is its exclusive licensing agreement with the University of Mississippi, which grants the company access to patented stable-isotope labeling techniques for cannabinoid molecules. This platform enables Core One Labs to generate analytical reference standards and develop novel drug candidates designed to treat a range of central nervous system disorders, including pain management, epilepsy and inflammatory conditions. The company operates a state-of-the-art development facility in Florida, where it advances its research-stage pipeline and provides contract manufacturing and custom synthesis services to strategic partners in the pharmaceutical, health-and-wellness and consumer goods sectors.

Core One Labs’ leadership team brings together experts in pharmaceutical chemistry, regulatory affairs and clinical development to guide the company through its transition from early-stage research to regulatory submission. While the company’s initial focus is on advancing IND-enabling studies for its lead cannabinoid formulations, it also explores strategic collaborations to broaden its product portfolio. Core One Labs serves customers and research collaborators primarily in the United States, with the potential to extend its technology to international markets as regulatory frameworks for cannabinoid-based medicines evolve.

Key Stats

• Today's Range: $0.0001 to $0.0001
• 50-Day Range: $0.00 to $0.03
• 52-Week Range: $0.00 to $0.20
• Volume: 1,112 shs
• Average Volume: 11,503 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CLABF Stock Analysis - Frequently Asked Questions

How have CLABF shares performed this year?

Core One Labs' stock was trading at $0.09 at the beginning of 2025. Since then, CLABF shares have decreased by 99.9% and is now trading at $0.0001.

How do I buy shares of Core One Labs?

Shares of CLABF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:CLABF
• CIK: 1640152
• Web: core1labs.com
• Phone: (866) 452-6731
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A